Dr. Roshanlal Aggarwal & Sons
⚠️ High Risk
FEI: 3009348470 • New Delhi • INDIA
FEI Number
3009348470
Location
New Delhi
Country
INDIAAddress
16 Netaji Subash Matrg, , New Delhi, , India
High Risk
FDA Import Risk Assessment
This firm has a significant history of FDA import refusals with notable violations.
Statistics
Score Breakdown
How is this score calculated?
Proprietary Algorithm
- 40% Violation Severity — AI-assessed (1-10)
- 30% Refusal Volume — Logarithmic scale
- 20% Recency — Decays over 5 years
- 10% Frequency — Refusals per year
© ImportRefusal.com Original Analysis
Violation Summary
UNAPPROVED
The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a new drug within the meaning of Section 201(p) without an approved New Drug Application (NDA).
Refusal History
| Date | Product | Violations | Division |
|---|---|---|---|
| 11/13/2024 | 66XBY05HOMEOPATHIC GASTROINTESTINAL | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 11/13/2024 | 66XBY07HOMEOPATHIC MULTIPLE INDICATIONS | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 11/13/2024 | 66XBY01HOMEOPATHIC ANALGESIC | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 11/5/2024 | 66XBL05HOMEOPATHIC GASTROINTESTINAL | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 8/16/2024 | 65CDY99NUTRIENT/TONIC N.E.C. | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 12/7/2023 | 66VBA99MISCELLANEOUS PATENT MEDICINES, ETC. | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 9/7/2023 | 62GDK99ANTI-INFLAMMATORY N.E.C. | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 3/12/2021 | 66VCY99MISCELLANEOUS PATENT MEDICINES, ETC. | 75UNAPPROVED | Division of Northern Border Imports (DNBI) |
| 3/12/2021 | 61RDY11ACTIVATED CHARCOAL (ANTIDOTE) | 75UNAPPROVED | Division of Northern Border Imports (DNBI) |
| 3/12/2021 | 60WDY01ALBENDAZOLE (ANTHELMINTIC) | 75UNAPPROVED | Division of Northern Border Imports (DNBI) |
Frequently Asked Questions
What is Dr. Roshanlal Aggarwal & Sons's FDA import refusal history?
Dr. Roshanlal Aggarwal & Sons (FEI: 3009348470) has 10 FDA import refusal record(s) in our database, spanning from 3/12/2021 to 11/13/2024.
What is an FEI number?
FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. Dr. Roshanlal Aggarwal & Sons's FEI number is 3009348470.
What types of violations has Dr. Roshanlal Aggarwal & Sons received?
Dr. Roshanlal Aggarwal & Sons has been cited for 1 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.
Where does this information about Dr. Roshanlal Aggarwal & Sons come from?
All FDA import refusal data for Dr. Roshanlal Aggarwal & Sons is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.
Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.